Based on the YIDU TECH INC. DL -00002 stock forecast from 0 analysts, the average analyst target price for YIDU TECH INC. DL -00002 is not available over the next 12 months. YIDU TECH INC. DL -00002’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of YIDU TECH INC. DL -00002 is Slightly Bearish, which is based on 2 positive signals and 3 negative signals. At the last closing, YIDU TECH INC. DL -00002’s stock price was EUR 0.51. YIDU TECH INC. DL -00002’s stock price has changed by +15.91% over the past week, +8.97% over the past month and -22.14% over the last year.
No recent analyst target price found for YIDU TECH INC. DL -00002
No recent average analyst rating found for YIDU TECH INC. DL -00002
Company Overview YIDU TECH INC. DL -00002
Yidu Tech Inc. provides healthcare solutions built on big data and artificial intelligence technologies in Mainland China, Brunei, and internationally. The company operates through Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and Others segments. The Big Data Platform and Solutions segment offers data intelligence platforms and data analytics-driven solutions to hospitals, other healthcare institutions, regulators, and policy makers. This segment also provides applications and solutions to hospitals focusing on research, clinical diagnosis and treatment, and hospital operations management; DPAP/Eywa platforms for hospitals and medical institutions; and intelligent research and clinical and management solutions to medical customers. The Life Sciences Solutions segment offers analytics-driven clinical development, real-world evidence (RWE)-based research, and digital commercialization solutions to pharmaceutical, biotech, medical device, and other companies. The Health Management Platform and Solutions segment provides health management platform application and solution services; and insurance technology and solutions to insurance companies, agencies, and related regulators and policy makers. This segment also engages in the distribution of insurance companies products; and sale of pharmaceutical products and related hardware and other services, as well as offers personalized digital therapies and out-of-hospital care services. The Others segment is involved in the sale of computer hardware. It also engages in the sale of medical devices; insurance brokerage activities; and medical, computer technology development, and investment holding activities. Yidu Tech Inc. was incorporated in 2014 and is headquartered in Beijing, China. Address: No. 9 Building of Huayuan North Road, Beijing, China Read Less
Yidu Tech Inc. provides healthcare solutions built on big data and artificial intelligence technologies in Mainland China, Brunei, and internationally. The company operates through Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions,...Read More
N/A
N/A
944
March
EUR
Germany
Adjusted Closing Price for YIDU TECH INC. DL -00002 (0EL:F)
Loading...
Unadjusted Closing Price for YIDU TECH INC. DL -00002 (0EL:F)
Loading...
Share Trading Volume for YIDU TECH INC. DL -00002 Shares
Loading...
Compare Performance of YIDU TECH INC. DL -00002 Shares
As per our most recent records YIDU TECH INC. DL -00002 has 944 Employees.
Sorry we do not have any infomation available on YIDU TECH INC. DL -00002's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0EL:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
